Mirizzi syndrome is a rare complication of gallstone disease that can lead to serious health conditions. It can be difficult to diagnose without proper imaging tests, and if not discovered early, it can lead to morbidity or death. Treatment is usually surgical, and early diagnosis is crucial for a good prognosis.
Mirizzi syndrome is a rare complication of gallstone disease. When a gallstone blocks the common hepatic duct, thus preventing bile from flowing out of the liver, jaundice can develop. Mirizzi syndrome occurs in about 0.1 percent of patients with gallstone disease and, as such, can be difficult to diagnose without the proper imaging tests. If not discovered early, Mirizzi syndrome can lead to morbidity or death. Dr. Pablo Luis Mirizzi, an Argentine physician, was the first to describe the syndrome in 1948.
The liver purifies the blood supply of the body and removes wastes and toxins from it. This waste is called bile. The gallbladder is an organ that stores bile until the body can use it to break down fat and cholesterol in the digestive system. When a gallstone blocks the drainage of bile into the gallbladder, the bile is then blocked in the liver. The body’s inability to drain bile could lead to serious health conditions due to the buildup of toxins, which is why it can be important to be able to pinpoint the problem.
There may not be any consistent or unique clinical presentations to differentiate Mirizzi syndrome from other more common forms of obstructive jaundice. It can also be misinterpreted as a more serious disease, such as pancreatic cancer or cholangiocarcinoma, a cancer of the bile duct. If present, symptoms may include cholecystitis, a sudden inflammation of the gallbladder; jaundice, a yellowish discoloration of the skin due to a buildup of dead red blood cells in the body; or high levels of bilirubin, which can be tested with a blood sample.
When a patient does not respond to common treatments for gallstone disease, Mirizzi syndrome can be suspected. A sonogram, computed tomography (CT) axial scan, and magnetic resonance cholangiopancreatography (MRCP) are common initial tests. Endoscopic retrograde cholangiopancreatography (ERCP), however, is typically the most effective in diagnosing Mirizzi syndrome and usually offers the most detailed information about the blockage and any abnormalities.
Treatment of Mirizzi syndrome is usually surgical. Typically, the gallbladder is removed or the common bile duct is reconstructed. Open surgery has shown good short- and long-term results. Laparoscopic surgery, however, has been shown to lead to increased mortality rates. Endoscopic treatment may serve as an alternative in high-risk patients, such as the elderly or those with multiple physical ailments.
Other treatments may include ERCP, a procedure that combines endoscopy and fluoroscopy, thus allowing for a very detailed view of the blockage. Lithotripsy, which involves using shock waves to remove or dissolve stones, may also be used. Prognosis is often strongly influenced by early diagnosis, although clinicians generally should be advised of any recurring or chronic symptoms.
Protect your devices with Threat Protection by NordVPN
